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Abstract
Background: Falls, associated injuries and fear-of-falling are common in adults with RA. Fear-of-falling can be a
major consequence of, and as debilitating as falling, resulting in a cycle of activity restriction, reduced quality of life,
institutionalisation and potentially increase risk of falls. The objective of this study was to examine the relationship
between fear-of-falling and risk factors associated with fear-of-falling in adults with rheumatoid arthritis (RA) over a
1 year period.
Methods: Five hundred fifty-nine patients with RA were recruited from four outpatient clinics in this prospective
cohort study. Baseline assessments included socio-demographic, medical and lifestyle related risk factors. Fall
incidence was prospectively obtained monthly using postal cards over a 1 year period. Fear-of-falling was assessed
at baseline and 1 year using the Short Falls Efficacy Scale-International (Short FES-I). Logistic regression was used to
determine the association between high fear-of-falling (Short FES-I > 11) at baseline (outcome) and a range of
putative predictor variables including previous falls, and also baseline factors associated with a high fear-of-falling at
follow-up.
Results: Five hundred thirty-five (ninety-six percent) participants (mean age 62.1 yrs.; 18–88 yrs) completed 1 year
follow-up and of these, 254 (47%) completed the Short FES-I questionnaire at 1 year. In a multivariate model, a
history of multiple falls (OR = 6.08) higher HAQ score (OR = 4.87) and increased time to complete the Chair Stand
Test (OR = 1.11) were found to be independent predictors of high fear-of-falling and had an overall classification
rate of 87.7%. There were no significant differences found in fear-of-falling at 1 year follow-up in those who
reported falls during the study, participant’s baseline fear appeared to predict future fear, regardless of further falls.
Conclusions: Fear-of-falling is significantly associated with previous falls and predictive of future falls and fear. RA
patients would benefit from fall prevention measures whether or not they have previously fallen.
Keywords: Fear-of-falling, Falls, Physical function, Rheumatoid arthritis, Prospective
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: emma.stanmore@manchester.ac.uk
1School of Health Sciences and Manchester Academic Health Science Centre
(MAHSC), Jean McFarlane Building, University Place, University of Manchester,
Manchester M13 9LP, UK
2Manchester University NHS Foundation Trust, M13 9WL Manchester, UK
Full list of author information is available at the end of the article
Stanmore et al. BMC Musculoskeletal Disorders          (2021) 22:260 
https://doi.org/10.1186/s12891-021-04068-0
Introduction
Patients with rheumatoid arthritis (RA) are at high risk
of falls [1–3] and their associated injuries, including frac-
tures and adverse psychological effects [1, 4, 5]. Given
the adverse consequences of falls, it is not surprising that
many people have a fear-of-falling. Such fear-of-falling
can be as debilitating as falling itself and can result in
activity restriction, reduced quality of life, increased use
of medication, institutionalisation and may also increase
the risk of injurious falls [6–10]. Fear-of-falling is not ex-
clusively determined by physical weakness; many people
with poor balance or a history of previous falls remain
confident and do not report a fear-of-falling [11]. Al-
though having a fall is linked with the development of
fear-of-falling, fear-of-falling is not uncommon among
those who have never fallen [12–14]. Falls and fear-of-
falling are not limited to older people and research sug-
gests they may affect younger as well as older adults with
RA [15, 16]. Despite this, there are few data concerning
the occurrence and determinants of fear-of-falling
among people with RA [3]. Prevalence of fear-of-falling
in cross-sectional RA studies shows marked variability
(range:16–67%). This may in part be related to the study
population (women only, small samples or frail older pa-
tients), inconsistent definitions of fear-of-falling and use
of different assessment measures [5, 16–20]. To date,
there are no prospective data concerning fear-of-falling
or factors which predict fear-of-falling in adults with RA.
The aim of this analysis was to determine factors linked
with high fear-of-falling in men and women with RA,




Patients with a diagnosis of RA, based on the 2010
American College of Rheumatology classification criteria
for RA [21] were consecutively recruited from four
rheumatology clinics in the Northwest of England. Par-
ticipants were excluded from the study if they were
under the age of 18 years or if they were unable to give
informed consent, as assessed by a trained research
nurse. Data collection, analysis and reporting were com-
pleted between August 2008 and September 2013 and
ethical approval for the study was obtained from the Na-
tional Research Ethics Committee, reference 08/H1009/
41 and written informed consent was obtained in ac-
cordance with the Declaration of Helsinki [22].
Baseline assessment
Participants were assessed at baseline by a trained re-
search nurse. This included an interviewer assisted ques-
tionnaire that included socio-demographic questions
(gender, age, ethnicity, employment status, marital
status), information about falls and fear-of-falling, and
the underlying RA. A number of performance measures
were also performed (see below).
i). Fear-of-falling, falls
At baseline the seven-item Short FES-I [23] was com-
pleted to measure confidence in performing a range of
activities of daily living without falling. Activities include
getting dressed or undressed, taking a bath or shower,
getting in or out of a chair, going up or down stairs,
reaching, walking up or down a slope, going out to a so-
cial event. A score is obtained by adding all the scores
on all items together to give a total that ranges from 7
(no fear) to 28 (severe concern) [23]. Cut off points have
been adopted to differentiate between lower and higher
levels of fear-of-falling concern (7–10 = low concern,
11–28 = high concern) [11]. Participants were asked at
baseline about their 1 year history of falls. A fall was
classified using the Prevention of Falls Network Europe
(ProFaNE) definition of, “an unexpected event in which
participants come to rest on the ground, floor, or other
lower level” [24].
ii). Medical and functional assessments
RA status was assessed using the Disease Activity
Score (DAS28) [25]. Self-reported functional status was
measured using the Health Assessment Questionnaire
(HAQ) that measures patients’ perceptions of difficulties
in performing activities in daily living, the need for
equipment and physical assistance to perform tasks [26].
The validated Falls Risk Assessment Tool (FRAT) was
used to measure falls risk [27]. Patients were also asked
questions about levels of pain and fatigue using visual
analogue scales (VAS) [28, 29], vision [30] and about any
previous fractures, surgery, co-morbidities, or joint re-
placement(s) [31] and all verified using medical records.
Medical records were also used to check medication, in-
cluding steroid use and previous medical history [32].
Lower limb muscle strength was assessed using the
Chair Stand Test [33] and balance was measured using
the Four-Test Balance Scale [34].
Follow up
Participants were asked to complete, over a course of a
year, monthly follow-up of falls using prepaid, pread-
dressed calendar postcards that were filled in daily [35].
After 1 year participants were sent a postal questionnaire
that included the Short FES-I [23].
Sample size
The sample size calculation was based on fall rates as
this was the primary focus of the study [1]. Based on
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data from retrospective studies [16, 31, 36] it was calcu-
lated that to estimate a fall rate of 0.3 falls/person year. a
sample size of 495 (i.e. 550 people before an assumed
10% drop-out rate) would be able to estimate this to a
precision of +/− 0.04 falls/person year (Clopper-Pearson
[37], using StatsDirect version 3.1.14 [38]).
Analysis
Statistical analysis was conducted using SPSS [39] and R
version 3.4.3 [40]. Independent group t-tests for nor-
mally distributed data, or the equivalent non-parametric
tests were used when appropriate to examine differences
between those with low and high fear-of-falling. Paired
t-tests or the equivalent non-parametric tests were used
to examine differences between baseline and 1 year fol-
low up. Chi-squared tests (or Fisher’s Exact test) were
used to examine the differences in categorical variables
between independent groups. Similarly ANOVA or the
equivalent non-parametric test were used to compare
between multiple independent groups. Bonferroni ad-
justments for multiple testing are considered in the in-
terpretation of p-values (Table 2). The Short FES-I data
(range: 7–28) were transformed into a binary variable in-
dicating low (7–10) and high (11–28) fear-of-falling [11].
Checks were made to ensure that the sample remaining
in the follow-up were not systematically different from
non-responders. Binary logistic regression was used to
calculate odds ratios (OR) and 95% confidence intervals
(CI) for age and gender and all fear-of-falling risk associ-
ated variables including salient interaction terms. Model
diagnostics (Hosmer-Lemeshow goodness-of-fit test, Q-
Q plot for outliers) were checked and were satisfied [41].
Model building was conducted by first examining effect
sizes in univariate logistic models using clinically rele-
vant variables, and testing for multi-collinearity (variance
inflation factors) in multivariate models. These model-
building checks were satisfied.
Results
Participants
A total of 559 participants completed the baseline as-
sessments (Fig. 1) and 535 (96%) completed follow up of
falls and remained in the study at 1 year (incidence of
falls data reported elsewhere) [1]. Forty-seven percent
(n = 254) of the participants completed the second postal
Short FES-I questionnaire after 1 year. The mean age of
participants was 62.1 years (SD = 12.8, median = 63;
range 18–88) and 386 (69.1%) were women. The major-
ity of participants were married or living with a partner
(n = 378, 69.7%) and were of white British ethnicity and
born in the UK (n = 528, 94.5%). Over half of the partici-
pants were retired (n = 327, 58.5%), and 14.7% were un-
able to work due to their disabilities (n = 82). About a
quarter of participants (24%; n = 134) continued to be
employed. The demographic, disease characteristics and
fall risk factor variables of the study population at base-
line (n = 559) and those continuing to the 1 year follow
up (n = 254) are shown in Table 1 and demonstrate simi-
lar characteristics. The characteristics of those partici-
pants who did not complete the follow up questionnaire
(n = 281, 53%) were also similar to those who did
complete.
Occurrence of falls
Detailed results on the incidence, risk factors and conse-
quences of the falls are reported elsewhere [1, 15].
Prevalence of fear-of-falling
At baseline, 69.9% of participants scored in the high
fear-of-falling range (95% CI 66.1, 73.7%). At follow up
71.7% participants scored in the high fear-of-falling
range (95% CI 65.4, 76.5%).
Determinants of fear-of-falling
i). Retrospective data
Those who reported a fall in the previous year (n =
242) had a significantly higher Short FES-I score at base-
line than those who reported no previous falls (n = 17.4
vs 13.8; p < 0.001). An independent t-test was used to
compare the 1 year history of falls and the 1 year follow
up Short FES-I score. There were no significant differ-
ences between the groups in mean follow up Short FES-
I scores (t = − 1.5, df = 480, p = 0.1, 95% CI -2.6, 0.4).
Within the items of Short FES-I, getting dressed/un-
dressed and getting into-out of a chair were of much less
concern than the other items to the participants at base-
line (p < 0.001).
Women (mean Short FES-I score = 16.0) had signifi-
cantly higher fear-of-falling scores than men (mean
Short FES-I score = 16.0 vs 13.9 respectively; t = − 3.7,
df = 532, p < 0.001, 95% CI –3.23, − 1.01). Concerns
about fear-of-falling consistently increased with age (in
bands of up to 34, 35 to 44, 45 to 54, 65 to 74 and over
75 years; χ2 = 12.6, df = 1, p < 0.001).
Disease related factors
When compared with participants who had low fear-of-
falling, participants who reported high concerns about
fear-of-falling generally had more swollen/tender joints,
higher DAS28, pain, fatigue and HAQ scores indicating
more active RA disease and poorer physical function (all
p ≤ 0.002) (Table 2). They also had more co-morbid con-
ditions and had poorer lower limb strength as evidenced
by more time needed to complete the five Chair Stand
test.
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At baseline, participants reporting high fear-of-falling
concerns were more likely to be taking psychotropic
medication, four or more medicines and steroids. High
fear-of-falling levels were also more common in women
and high fear-of-falling participants were associated with
having a history of one or more falls, a history of stroke or
Parkinson’s disease and a history of previous surgery and
joint replacements. High levels of fear were also more
common in participants who complained of feeling dizzy
or unsteady, having painful feet, poorer balance and lower
limb strength as tested by the four test balance scale and
the ability to perform five chair stands (Table 2).
Fig. 1 Flow diagram of study recruitment and follow up
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ii). Prospective data
Those who reported a fall during the study had a sig-
nificantly higher mean baseline Short FES-I score of 16.8
than non- fallers at 14.4 (t = − 4.3, p < 0.001, 95% CI -3.5,
− 1.3).
To examine whether fear-of-falling increased following
a fall, an independent t-test was used on the change in
Short FES-I score (the difference between follow-up
Short FES-I score and baseline Short FES-I score). There
were no significant differences in fear-of-falling found
between non-fallers and fallers at baseline or follow-up
Table 1 Participant characteristics at baseline and 1 year follow up
Variable Baseline (n = 559) 1 year follow up (n = 254)
Demographics
Female n (%) 386 (69.1) 174 (68.5)
Agea 62 (12.8) 62 (10.0)
White British n (%) 534 (95.5) 240 (94.5)
Married/living with partner n (%) 378 (69.7) 199 (80.6)
Employed n (%) 134 (24.0) 55 (21.7)
Disease factors
Swollen joints (0–28)a 4.6 (6.2) 4.3 (6.0)
Tender joints (0–28)a 5.3 (6.9) 5.4 (7.0)
DAS28 score (0–10)a 4.1 (1.6) 4.1 (2.6)
Taking steroids at baseline n (%) 117 (20.9) 47 (18.5)
VAS pain score (0–10)a 3.9 (2.6) 3.8 (2.6)
VAS fatigue score (0–10)a 4.7 (2.8) 4.5 (2.8)
HAQ score (1–4)a 2.4 (0.9) 2.4 (0.8)
Medical history
History of fractures n (%) 228 (40.8) 107 (42.1)
Poor vision (reg. Blind, v poor or poor) n (%) 46 (8.2) 19 (7.5)
Number of co-morbidities a 2.0 (2.0) 1.9 (1.9)
Previous surgery n (%) 408 (73.0) 187 (73.6)
Previous joint replacementsa 0.2 (0.5) 0.2 (0.5)
Injuries from previous falls a n (%) 1.6 (1.4) 1.6 (1.4)
Fall risk factors
History of stroke/Parkinsons n (%) 38 (6.8) 20 (7.9)
Psychotropic medication n (%) 104 (18.6) 51 (20.1)
Four or more types of medicines n (%) 431 (77.1) 196 (77.2)
Feeling dizzy or unsteady n (%) 370 (66.2) 167 (65.7)
Painful feet n (%) 431 (77.2) 192 (75.5)
Short FES-I score (7–28)a 15.3 (6.5) 14.8 (6.3)
Four test balance scale
Fail at each level
Unsuccessful n (%) 39 (7.0) 13 (5.1)
Feet together stand n (%) 13 (2.3) 7 (2.8)
Semi-tandem stand n (%) 216 (38.6) 93 (36.6)
Tandem stand n (%) 116 (20.8) 55 (21.7)
One leg stand n (%) 175 (31.3) 86 (33.9)
Able to complete 5 chair stands n (%) 484 (86.6) 217 (85.4)
Time taken for 5 chair stands (Seconds) a 21.0 (12.2) 21.1 (13.2)
amean (SD)
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Table 2 Fear-of-falling at baseline and 1 year follow-up
Variable Baseline high fear-of-
falling
(n = 390)b
Baseline low fear of
falling
(n = 168)
Follow up high fear-of-
falling
(n = 181)




Female (n/%) 287 (73.6)** 99 (58.9) 122 (67.4) 52 (71.2)
Agea 63 (12.7)** 59.9 (12.7) 62 (10.7)** 62 (10.0)
Disease factors
Swollen joints (0–28) a 5 (6.7)** 3 (4.7) 5.0 (6.4)** 2.6 (4.4)
Tender joints (0–28) a 6 (7.3)** 3 (4.9) 6 (7.2)** 4.1 (6.3)
DAS28 score (0–10) a 5 (1.5)** 3 (1.4) 5 (1.5)** 3 (1.6)
Taking steroids at baseline (n/%) 94 (24.1)* 23 (13.7) 42 (23.2)** 5 (6.8)
VAS pain score (0–10)a 5 (2.6)** 3 (2.2) 4 (2.5)** 3 (2.3)
VAS fatigue score (0–10)a 5 (2.6)** 3 (2.6) 5 (2.6)** 3 (2.6)
HAQ score (1–4) a 3 (0.7)** 2 (0.5) 3 (0.8)** 2 (0.6)
Medical history
History of fractures (n/%) 162 (41.5) 65 (38.7) 82 (45.3) 25 (34.2)
Poor vision (reg. Blind, v poor or
poor) (n/%)
37 (9.5) 9 (5.4) 13 (7.2) 6 (8.2)
Previous surgery (n/%) 291 (74.6) 116 (69.0) 137 (75.7) 50 (68.5)
Previous joint replacements (n/%) 99 (25.6) 26 (15.5) 44 (24.6) 1 5 (15.1)
History of injuries from previous falls
(n/%)
107 (30.7)** 17 (11.6) 48 (29.8)* 8 (12.1)
Fall risk factors
No falls in previous year (n/%) 190 (48.7)** 126 (75.0) 91 (50.3)** 54 (74.0)
History of single fall in previous year
(n/%)
87 (22.3) 33 (19.6) 42 (23.2) 13 (17.8)
History of multiple falls in previous
year (n/%)
113 (29.0) 9 (5.4) 48 (26.5) 6 (8.2)
History of stroke/Parkinson’s (n/%) 31 (7.9) 7 (4.2) 18 (9.9) 2 (2.7)
Psychotropic medication (n/%) 87 (22.3)** 17 (10.1) 40 (22.1) 11 (15.1)
Four or more types of medicines (n/
%)
328 (84.1)** 103 (61.3) 148 (81.8)* 48 (65.8)
Feeling dizzy or unsteady (n/%) 312 (80.0)** 57 (33.9) 136 (75.1)** 31 (42.5)
Painful feet (n/%) 321 (82.5)** 109 (64.9) 143 (79.4) 48 (65.8)
Four test balance scale (n/%)
Fail at each level
Unsuccessful 39 (10.0)** 0 (0.0) 13 (7.2)** 0 (0.0)
Feet together stand 13 (3.3) 0 (0.0)* 6 (3.3) 1 (1.4)
Semi-tandem stand 177 (45.4) 39 (23.2)* 75 (41.4) 18 (24.7)
Tandem stand 81 (20.8) 34 (20.2)* 41 (22.7) 14 (19.2)
One leg stand 80 (20.5) 95 (56.6)* 46 (25.4) 40 (54.8)
Able to complete 5 chair stands (n/%) 316 (81.0)** 167 (99.4) 145 (80.1)** 72 (98.6)




bData missing for 1 participant
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(t = 0.8, df = 249, p = 0.41). Therefore, having a fall or not
in the 1 year follow up did not appear significantly to
change levels of fear-of-falling in this group of partici-
pants.Short FES-I scores did not differ between women
and men at 1 year follow up (mean Short FES-I score =
15.3 vs 15.9 respectively; t = 0.8, df = 252, p = 0.41, 95%
CI -0.9, 2.3). There were also no significant differences
in levels of fear-of-falling with age (in bands of up to 34,
35 to 44, 45 to 54, 65 to 74 and over 75 year;χ2 = 0.07,
df = 1, p = 0.8).
Predictors of fear-of-falling
Following multivariable binary logistic regression, statis-
tically significant variables were: a history of multiple
falls (OR = 5.4, 95% CI 1.8 to 16.3, p = 0.02); painful feet
(OR = 2.3, 95% CI 1.1 to 4.52, p = 0.03), increased HAQ
score (OR = 7.8, 95% CI 3.9 to 15.6, p < 0.001), feeling
dizzy or unsteady (OR = 3.8, 95% CI 2.0 to 7.2, p < 0.001)
and increased time to complete the Chair Stand Test
(OR = 1.1, 95% CI 1.0 to 1.1, p = 0.048). There was an in-
verse association between high fear-of-falling and swol-
len joints (OR = 0.9, 95% CI 0.85 to 0.99, p = 0.02)
(Table 3). The fit of the predicted values in this logistic
regression model was 85.5% and these results were also
supported by a sensitivity analyses using bootstrapping
(1000).
A history of multiple falls (OR = 6.08, 95% CI 1.19 to
30.99, p = 0.03), higher HAQ scores (OR = 4.87, 95% CI
1.59 to 14.92, p = 0.006) and increased time to complete
the Chair Stand Test (OR = 1.11, 95% CI 1.01 to 1.20,
p = 0.02) were found to be the most significant predic-
tors for future fear-of-falling (Table 4). Previous fear
predicts future fear and 1 year later fear appeared to be
lower amongst women than men. This model had an
overall rate of correct classification of 87.7%. A sensitiv-
ity analyses using bootstrapping also supported these
conclusions from the multivariate logistic regression
model.
Discussion
This is the first study that has prospectively investigated
fear-of-falling and predictors for fear-of-falling in a sam-
ple of adults with RA. This study demonstrates that fear-
of-falling is an important problem for adults of all ages
with RA with some 70% of the population experiencing
high levels of fear-of-falling, not limited to older people.
Mean fear-of-falling scores were in the high fearful cat-
egory for participants at baseline and at 1 year follow up
and the prevalence of fear-of-falling appeared to increase
with age and to be higher in women. This is consistent
with community dwelling studies [8] and fear-related
avoidance of activities is known to be predictive of fu-
ture falls, physical frailty and reduced muscle strength
[12]. Fear-of-falling in people with RA may affect their
ability to carry out activities of daily living, such as going
out to do shopping or to participate in a social event
and so have negative psychological as well as physical
consequences [5].
The prevalence of fear-of-falling in this study is higher
than previous cross-sectional studies in those with RA
that measured having fear or not [5, 16, 43] but this
likely reflects the difference in measurement (Short FES-
I vs single item measure). Having a fall or not in the 1
year follow up did not appear significantly to change
levels of fear-of-falling in this group of participants.
Those who fell in the previous 1 year may already ex-
perience higher levels of fear-of-falling that remain con-
stant whether they fell again or not in the following 1
year.
Having had at least one previous fall was found to be
an independent risk factor for fear-of-falling and nearly
tripled the odds of having fear-of-falling. Increasing
HAQ scores (but not disease activity scores) and increas-
ing time to complete the Chair Stand Test (indicating a
decrease in physical functioning) are other important in-
dependent risk factors for fear-of-falling. These results
are similar to other studies that have demonstrated an
association between functional decline and fear-of-falling
in patients with RA [5, 19, 42, 43] and may be helpful in
designing a screening tool for modifiable risk factors for
patients at risk of fear-of-falling. By asking questions in
routine assessments and reviews about fear-of-falling,
falls and their context, health and social care practi-
tioners may identify patients who may be at risk of fall-
ing. If there is concern that a person is at risk of falling,
they can be referred to, or advised to see, a healthcare
professional particularly a geriatrician or physiotherapist
or falls prevention service if available, to further assess
their risk and treat modifiable risk factors. Thus a rec-
ommendation for clinicians from this study would be to
routinely monitor fear-of-falling amongst patients using
a validated tool such as the Short FES-I.
A systematic review and meta-analysis of 30 trials by
Kumar and colleagues found that exercise interventions
(aimed at reducing falls) that included gait, balance, co-
ordination, strength, resistance and functional tasks are
associated with a small to moderate reduction of fear-of-
falling in community-dwelling older adults [44]. How-
ever, a high risk of bias was noted throughout the in-
cluded trials and so these results should be interpreted
with caution, especially as most studies were short term
with little long term follow-up to examine if the effect
was sustained. There is good evidence that the home-
based Otago exercise programme (OEP) [45] and group-
based Falls Management Exercise (FaME) [46] strength
and balance programmes are effective in reducing falls if
progressive, tailored and reach a minimum effective
dose. However, no study to date has investigated the
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effectiveness of these programmes specifically with patients
with RA. Therefore, well designed future studies are needed
to investigate whether exercise interventions are effective in
reducing fear-of-falling, and falls in adults with RA.
This study has a number of limitations, these include the
falls recorded during the study rely on self-report, low follow
up response rate for the Short- FES-I and the method of re-
cruitment of the participants from rheumatology clinics that
may have resulted in participants with more moderate to se-
vere RA or more progressive disease than the general pri-
mary care population. A measure of physical activity may
have given further insight into whether fear-of-falling affected
levels of activity. The rheumatology clinics were all based in
the Northwest of England and therefore, the results should
be interpreted with caution as they may not be generalisable
to other populations.
Table 3 Associations between risk factors and baseline fear-of-falling using multivariable binary logistic regression (high fear, n =
390/low fear, n = 168)
Risk factor Score Odds ratio
(OR)




Age 18–88 0.97 0.95,1.00 0.1
Number of swollen joints 0–28 0.91 0.85,0.99 0.02
Number of tender joints 0–28 0.97 0.89,1.04 0.4
DAS28 Score 0.1–8.9 1.37 0.95,1.99 0.1
Psychotropic medicines No (referent) 1.15 0.44,3.00 0.8
Yes
Four or more types of medicines No (referent) 1.74 0.82,3.68 0.1
Yes
Taking steroids at baseline No (referent) 1.33 0.58,3.03 0.5
Yes
History of stroke or Parkinson’s disease No (referent) 0.53 0.14,1.92 0.3
Yes
VAS pain score 0–10 1.00 0.85,1.16 0.9
VAS fatigue score 0–10 1.03 0.90,1.17 0.7
History of falls in previous 12 months 0 fall (referent)
1 fall







Number of joint replacement 0–6 0.87 0.57,1.33 0.5
History of previous injuries No (referent) 1.11 0.48,2.57 0.8
Yes
History of previous surgery No (referent) 0.66 0.33,1.30 0.2
Yes
Painful feet No (referent) 2.34 1.11,4.52 0.025
Yes
HAQ score 1.00–4.00 7.79 3.87,15.69 < 0.001
Four test balance scalea:
Semi- tandem stand 2 1.15 0.50,2.64 0.7
Tandem stand 3 0.71 0.30,1.67 0.4
One – leg stand 4 (referent)
Complaints of feeling dizzy or unsteady No (referent) 3.81 2.01,7.22 < 0.001
Yes
Time taken for chair stand test 4–104 s 1.05 1.00, 1.10 0.048
Hosmer-Lemeshow goodness of fit test.
x2 = 5.0, df = 8, p = 0.759. Nagelkerke R2 = 61.3%
aUnable to add ‘feet together stand’ category as too few participants
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Conclusions
Fear-of-falling is common in adults with RA and this may
alter activity levels and social engagement and may affect
the ability to function independently. Fear-of-falling is sig-
nificantly associated with previous falls and markers of
poor function and is predictive of future falls and future
fear. RA patients who report high fear-of-falling may
benefit from fall prevention measures whether or not they
have previously fallen, and exercise interventions to re-
duce fear-of-falling should also be considered.
Table 4 Associations between risk factors and 1 year fear-of-falling using multivariable binary logistic regression (high fear, n = 181/
low fear, n = 73)
Risk factor Score Odds ratio
(OR)
OR 95% Confidence Intervals p-value
Gender Male (referent) 0.21 0.07, 0.63 0.05
Female
Age 18–88 0.95 0.89,1.00 0.06
Number of swollen joints 0–28 0.99 0.86, 1.13 0.8
Number of tender joints 0–28 0.92 0.82,1.03 0.1
DAS28 Score 0.1–8.9 1.31 0.70,2.44 0.4
Psychotropic medicines No (referent) 1.11 0.31,4.00 0.9
Yes
Four or more types of medicines No (referent) 0.81 0.26,2.52 0.7
Yes
Taking steroids at baseline No (referent) 3.60 0.82,15.74 0.09
Yes
History of stroke or Parkinson’s disease No (referent) 1.30 0.16,10.47 0.8
Yes
VAS pain score 0–10 0.96 0.75,1.22 0.7
VAS fatigue score 0–10 1.19 0.96,1.46 0.1
History of falls in previous 12 months 0 fall (referent)
1 fall







Number of joint replacements 0–6 0.83 0.23,3.04 0.8
History of injuries from previous falls No (referent) 0.81 0.22,2.95 0.8
Yes
History of previous surgery No (referent) 1.15 0.41,3.28 0.8
Yes
Painful feet No (referent) 0.92 0.32,2.64 0.8
Yes
HAQ score 1.00–4.00 4.87 1.59,14.92 0.006
Four test balance scalea:
Semi- tandem stand 2 0.81 0.24,2.69 0.7
Tandem stand 3 1.40 0.37,5.40 0.6
One – leg stand 4 (referent)
Complaints of feeling dizzy or unsteady No (referent) 1.67 0.65,4.27 0.29
Yes
Time taken for chair stand test 4–104 s 1.11 1.01, 1.20 0.02
Baseline fear-of-falling Low (referent) 30.05 1.42,637.18 0.03
High
Hosmer-Lemeshow goodness of fit test
x2 = 6.9, df = 8, p = 0.545. Nagelkerke R2 = 58.6%
aUnable to add ‘feet together stand’ category as too few participants
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